Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

Market Cap	2.26B +62.4%
Revenue (ttm)	979.90M +8.8%
Net Income	82.09M +102.6%
EPS	7.76 +229.3%
Shares Out	10.52M
PE Ratio	27.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,400
Average Volume	3,980
Open	205.20
Previous Close	214.35
Day's Range	205.20 - 215.00
52-Week Range	81.10 - 335.00
Beta	-0.02
RSI	39.83
Earnings Date	May 22, 2026

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health su...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1999
• Employees: 636
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MADHAVBAUG

Financial Performance

In fiscal year 2025, NSE:MADHAVBAUG's revenue was 898.47 million, a decrease of -9.55% compared to the previous year's 993.31 million. Earnings were 71.36 million, an increase of 260.34%.